result and others obtained with the various analogues suggest that, while enzyme-substrate hydrogen bonding may play a role in the A-kinase catalysed phosphoryl group transfer reactions, the a-N-methylated and depsi-containing peptide 1 analogues react at relative rates which require additional explanations. Among the explanations for our results that must be considered are the possibilities that the substitutions of N-methyl groups in the amide bonds cause disruptive peptide-enzyme steric interactions or that intrapeptide steric interactions could prevent a particular peptide analogue from assuming the conformation recognizable by A-kinase. The nature of such steric interactions has been probed in the second aspect of our work (Bramson et al., 1987) which is briefly described herein. As already mentioned, by means of studies utilizing n.m.r. spectroscopy evidence has been obtained that A-kinase probably binds Leu-Arg-Arg-Ala-Ser-Leu-Gly, peptide 1, in one of two extended coil conformations (A or B, described by Rosevear et al., 1984). We have considered, therefore, the possibility that the relative reactivities of a series of N-methylated peptides based on the structure of peptide 1 might be related to the ease with which each peptide can assume the A or B Conformation. The N-methylated peptides which we examined are those illustrated in Table 1 and also the additional ones illustrated in Table 2. Utilizing computer graphics, on the basis of estimates of the magnitude of the steric interactions that would be induced by N-methylation of the amide groups in peptide 1 derivatives locked in either conformation, the ability of each peptide analogue to form a particular conformation was predicted. We found that there was a good correlation between the catalytic activity of A-kinase in the phosphorylation of the N-methylated peptides and the ability of each peptide to form conformation A but not B. To test these findings further we probed the possibility that the reactivity of a relatively unreactive N-methylated peptide might be partially restored by a second change which allowed the peptide to assume conformation A. The finding that such restoration could be achieved together with our other results suggests that when peptide 1 is bound in the enzymic active site it has a conformation which resembles structure A much more closely than structure B (Bramson et al., 1987). In the third aspect of our work we have probed whether when other protein kinases are observed to catalyse the phosphorylation of the same peptide sequences as does A-kinase, the protein kinases utilize the same conformation of the peptide in their reactions (Thomas et al., 19873). We have employed, therefore, the reactions of the conformationally restricted N-methylated peptides which have been utilized as substrates for A-kinase in examining the conformational requirements of the cyclic GMP-dependent protein kinase (G-kinase). The G-kinase is homologous in sequence to A-kinase (Taiko et al., 1984) and has comparable substrate specificities (Lincoln & Corbin, 1977). Our kinetic results with the N-methylated peptides show that, despite the ability of the G-kinase to bind the peptides in a conformation resembling that of conformation A, the Genzyme is more tolerant of backbone methylation than in A-kinase. As a result, while the reactivity of the G-kinase with the prototypic peptide substrate Leu-Arg-Arg-Ala-SerLeu-Gly, peptide 1, is about 10-fold less than the reactivity with the A-kinase, as assessed from the relative magnitudes of k,,,/K,, when the parent peptide was N-methylated at the amide group of the Ser’ residue, the resultant peptide substrate was at least 700-fold more reactive with G-kinase than with A-kinase. Our observations with the peptide which is N-methylated at the phosphorylatable serine residue of peptide 1 show that backbone methylation can represent an approach to making peptide substrates which are selective for a particular kinase (Thomas et al., 19873). This finding encourages us to pursue the possibility that N-methylation of peptides might provide a method for targeting peptidebased inhibitors to selected protein kinases. Partial support of this research by National Institutes of Health Grant GM 32204 is gratefully acknowledged.
Read full abstract